In an effort to expand across Latin America, Khiron Life Sciences Corp. (OTCQX: KHRNF) recently partnered with e-commerce company Rappi to launch and distribute a line of CBD products to Uruguay and Costa Rica.
Khiron CEO Alvaro Torres told Benzinga the collaboration is “focused on the new low touch economy.”
“We are starting with the distribution of the beauty brand Kuida, but in the future, we are projected to reach other markers and products,” Torres said, citing how using Rappi is a “great strategy” considering it is “already in everybody’s phone.”
Rappi has been touted as a so-called “super app” in Latin America, specializing in on-demand home delivery.
Khiron, meanwhile, is a major industry player in its own right. It’s considered one of the “big four” cannabis producers in Colombia and has been reaching new consumers in other countries.
Khiron also ventured into Peru where it filled over 3,000 prescriptions of CBD medical cannabis. Before that, it set up a deal with Uruguay’s government on pre-clinical medical cannabis studies — each focusing on the effects of its three licensed strains.
The strains were “proven to be of …